A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid Arthritis

NCT02309359 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

345

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL: ALX-0061
OTHER: Placebo
DRUG: Methotrexate

Sponsor

Ablynx, a Sanofi company